IGF-1 LR3 is a synthetic analog of insulin-like growth factor-1 (IGF-1), modified with an arginine substitution at position 3 and an extended N-terminal sequence. These structural modifications are studied for their influence on receptor binding affinity and metabolic stability in laboratory settings.
IGF-1 LR3 is utilized in controlled in vitro and preclinical research models examining growth factor signaling pathways and cellular regulatory mechanisms.
Scientific Research Context
IGF-1 and its analogs have been widely referenced in peer-reviewed scientific literature in connection with:
-
IGF-1 receptor (IGF-1R) signaling pathway analysis
-
PI3K/Akt and MAPK pathway research models
-
Cellular proliferation and differentiation studies
-
Skeletal muscle cell biology research
-
Glucose metabolism signaling investigations
-
Tissue growth and repair pathway modeling
-
Endocrine system regulatory mechanism studies
Published literature includes experimental studies conducted in cell cultures, animal models, and controlled human research environments exploring IGF-1–related biological activity. These references are provided strictly for scientific context and do not imply intended use of this product.